Skip to main content
Unit of study_

Neuropsychopharmacology - BMRI5013

Year - 2020

This elective unit will focus on neuropsychopharmacology as a tool for characterizing brain pathways and as a treatment for brain disorders. Students will be introduced to basic principles of pharmacology governing drug binding and metabolism that underlie the rationale for drug design. Links between brain circuitry and phenomenology of various brain disorders including chronic pain, anxiety and dementia will be examined to provide a rationale for chosen drug targets. Students will also examine the relationship between dosage, specificity and negative side effects of such drugs. There will be the opportunity critically to examine current directions in neuropharmacology research, the role of the pharmaceutical industry and potential new pathways for future drug design.

Full day workshops in weeks 2, 5 and 11

Online quiz (30%), Report (40%), Oral presentation (30%)

Specific reference material listed on eLearning


Faculty: Medicine and Health

Semester 1

24 Feb 2020

Department/School: Central Clinical School
Study Mode: Block mode
Census Date: 31 Mar 2020
Unit of study level: Postgraduate
Credit points: 6.0
EFTSL: 0.125
Available for study abroad and exchange: No
Faculty/department permission required? No
Mallet St
More details
Unit of Study coordinator: Dr Eryn Werry
HECS Band: 3
Courses that offer this unit

Non-award/non-degree study If you wish to undertake one or more units of study (subjects) for your own interest but not towards a degree, you may enrol in single units as a non-award student. Cross-institutional study If you are from another Australian tertiary institution you may be permitted to undertake cross-institutional study in one or more units of study at the University of Sydney.

To help you understand common terms that we use at the University, we offer an online glossary.